Comparing Aerobic to Resistance Training in Recovery From Cancer

This study has been completed.
Sponsor:
Information provided by:
Brooke Army Medical Center
ClinicalTrials.gov Identifier:
NCT00237926
First received: October 11, 2005
Last updated: July 29, 2008
Last verified: July 2008
  Purpose

The purpose of this study is to compare the health outcomes of a 12-week exercise program focused on aerobic training (using a treadmill) to a 12-week exercise program focused on resistance training (using Thera-Bands) in sedentary patients within 6 months of completing treatment for cancer.


Condition Intervention
Neoplasms
Behavioral: Exercise

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Comparing Aerobic to Resistance Training in Recovery From Cancer

Resource links provided by NLM:


Further study details as provided by Brooke Army Medical Center:

Primary Outcome Measures:
  • quality of life [ Time Frame: 12-weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • exercise tolerance [ Time Frame: 12-weeks ] [ Designated as safety issue: No ]

Enrollment: 58
Study Start Date: November 2005
Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
aerobic exercise
Behavioral: Exercise
aerobic or resistance training
Experimental: 2
Resistance Training
Behavioral: Exercise
aerobic or resistance training

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • have a biopsy-proven cancer diagnosis
  • be within six months of having completed chemotherapy or radiation therapy for treatment for cancer as determined by the primary physician
  • be ambulatory but sedentary (i. e., has not followed an exercise regimen of a minimum of 3 times per week for at least 20 minutes each session over the previous six weeks)
  • have an Eastern Cooperative Oncology Group (ECOG) Performance Status score of 0 asymptomatic) or 1 (symptomatic, fully ambulatory)
  • be at least 18 years old
  • be able to read and speak English
  • have a medical statement from either the patient's primary care provider or the primary oncologist indicating that participation in the program is not medically contraindicated

Exclusion Criteria:

  • following an exercise regimen a minimum of 3 times per week for at least 20 minutes each session within the previous 6 weeks
  • bone or joint destruction that could be aggravated with exercise
  • severe cognitive impairment identified by either the patient's medical care provider or by the study team
  • neuropathy-sensory common toxicity criteria (CTC) grade 3 (sensory loss or paresthesia interfering with activities of daily living) or grade 4 (permanent sensory loss that interferes with function) peripheral neuropathy
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00237926

Locations
United States, Texas
Brooke Army Medical Center
Fort Sam Houston, Texas, United States, 78234
Sponsors and Collaborators
TriService Nursing Research Program
Investigators
Principal Investigator: Stacey Young-McCaughan, RN, PhD Department of Defense
  More Information

No publications provided

Responsible Party: Stacey Young-McCaughan, The Geneva Foundation at Brooke Army Medical Center
ClinicalTrials.gov Identifier: NCT00237926     History of Changes
Other Study ID Numbers: N05-006
Study First Received: October 11, 2005
Last Updated: July 29, 2008
Health Authority: United States: Federal Government

Keywords provided by Brooke Army Medical Center:
Sleep
Fatigue
Exercise tolerance
Quality of life
Health status

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on June 18, 2013